RAD21 and neoplasm: In this study, we investigated the genomic determinants of high telomeric content across 89,959 tumor samples in the Foundation Medicine dataset and found that samples with high telomeric content were enriched in amplifications in RAD21 (8q23.1–8q24.12) or HGF (7q21.11) pan-cancer and within select disease ontologies.